Editas Medicine, Inc. (EDIT) Social Stream



Editas Medicine, Inc. (EDIT): $2.96

0.11 (-3.58%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

C

Add EDIT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#172 of 332

in industry

Featured Post From StockTwits About EDIT

$EDIT #CRBU #CRSP #BEAM #NTLA

Good news. Significant movement is on the horizon now that preliminary results are starting to filter through with CRISPR. And the results look good. Far too good for others to ignore. We’ve all talked about cash rich Moderna and it’s desire to make the natural move from mRNA to gene editing but what about Pfizer and the other big pharma’s? No way they’re going to allow Moderna to run away from the pack.
The CRISPR sector looks set to do a Tesla, capturing future medical dominance with its radical innovation in treating diseases and not just symptoms. Based on CRISPR’s early success and positive trials not to forget it’s radical overhaul of future medicine, Is it too early to see an explosion in share price? I think not!
The time is ripe and anyone selling their holdings will live in a world of regret for a long time.
Makeshthappn, published August 16, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!